| 000 | 01903 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517002123.0 | ||
| 264 | 0 | _c20150325 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1465-3621 | ||
| 024 | 7 |
_a10.1093/jjco/hyu182 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShimoyama, Naohito | |
| 245 | 0 | 0 |
_aEfficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain. _h[electronic resource] |
| 260 |
_bJapanese journal of clinical oncology _cFeb 2015 |
||
| 300 |
_a189-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdministration, Sublingual |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
| 650 | 0 | 4 |
_aBreakthrough Pain _xdrug therapy |
| 650 | 0 | 4 |
_aChronic Pain _xdrug therapy |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFentanyl _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMorphine _xadministration & dosage |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGomyo, Ikuo | |
| 700 | 1 | _aTeramoto, Osamu | |
| 700 | 1 | _aKojima, Keisuke | |
| 700 | 1 | _aHiguchi, Hitomi | |
| 700 | 1 | _aYukitoshi, Nobuyuki | |
| 700 | 1 | _aOhta, Eri | |
| 700 | 1 | _aShimoyama, Megumi | |
| 773 | 0 |
_tJapanese journal of clinical oncology _gvol. 45 _gno. 2 _gp. 189-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jjco/hyu182 _zAvailable from publisher's website |
| 999 |
_c24337090 _d24337090 |
||